Cyclacel Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
  • Cyclacel Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$25K, a 76.2% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$158K, a 154% decline year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$98K, a 106% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $1.74M, a 753% increase from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $204K, a 78.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$98K -$1.84M -106% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $1.74M +$1.54M +753% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $204K -$751K -78.6% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-11-29
2020 $955K +$399K +71.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $556K -$367K -39.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $923K -$105K -10.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $1.03M +$652K +173% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 $376K +$692K Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 -$316K -$104K -49.1% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 -$212K -$6.31M -103% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 $6.09M +$6.1M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 -$4K -$584K -101% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-26
2011 $580K +$992K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-26
2010 -$412K Jan 1, 2010 Dec 31, 2010 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.